A Prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: Report of an international randomized control trial-the priapism in sickle cell study

Journal of Andrology

Volumn 32, Issue 4, 2011, Pages 375-382

  Olujohungbe, Ade B ^a   Adeyoju, Adebanji ^b   Yardumian, Anne ^c   Akinyanju, Olu ^d   Morris, Julie ^e   Westerdale, Neil ^f   Akenova, Yetunde ^g   Kehinde, M O ^h   Anie, Kofie ⁱ   Howard, Joanna ^f   Brooks, Adrian ^j   Davis, Verna Angus ^k   Khoriatry, Adlette Inati ^l  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^b STEPPING HILL HOSPITAL   (United Kingdom)

^c NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^d Sickle Cell Foundation of Nigeria   (Nigeria)

^e WYTHENSHAWE HOSPITAL   (United Kingdom)

^f GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF IBADAN   (Nigeria)

^h LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

^j Henshaws Society for Blind People   (United Kingdom)

^k Manchester Sickle Cell and Thalassemia Centre   (United Kingdom)

^l Hafikk Hariri Hospital   (Lebanon)

more..

Author keywords

adrenergic agonists; Prophylaxis; Sexual health

Indexed keywords

EPHEDRINE; ETILEFRINE; PLACEBO; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ADOLESCENT; ADOLESCENT HEALTH; ADULT; AGE DISTRIBUTION; ANXIETY; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERABILITY; HEALTH INSURANCE; HEART PALPITATION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIAPISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL HEALTH; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; SIDE EFFECT; TACHYCARDIA; TREMOR; XEROSTOMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ERECTILE DYSFUNCTION; FOLLOW UP; MEDICAL RECORD; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDY; STUTTERING;

ADOLESCENT; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADULT; ANEMIA, SICKLE CELL; EPHEDRINE; ERECTILE DYSFUNCTION; ETILEFRINE; HUMANS; LOST TO FOLLOW-UP; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENT COMPLIANCE; PRIAPISM; PROSPECTIVE STUDIES; STUTTERING;

EID: 80052646750     PISSN: 01963635     EISSN: 19394640     Source Type: Journal    
DOI: 10.2164/jandrol.110.010934     Document Type: Article

References (21)

1. Abern MR, Levine LA. Ketoconazole and prednisone to prevent recurrent ischemic priapism. J Urol. 2009;182(4):1401-1406.
2. Adeyoju AB, Olujohungbe AB, Morris J, Yardumian A, Bareford D, Akenova A, Akinyanju O, Cinkotai K, O'Reilly P. Priapism in sickle cell disease; incidence, risk factors and complications: an international multicentre study. BJU Int. 2002;90(9):898-902.
3. Al Jam'a AH, Dabbous IA. Hydroxyurea in the treatment of sickle cell associated priapism. J Urol. 1998;159(5):1642.
4. Baruchel S, Rees J, Bernstein ML, Goodyer P. Relief of sickle cell priapism by hydralazine: report of a case. Am J Pediatr Hematol Oncol. 1993;15(1):115-116.
5. Burnett AL, Bivalacqua JT, Champion HC, Musicki B. Long term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology. 2006;67(5):1043-1048.
6. Cummins D, Heuschkel R, Davies SC. Penicillin prophylaxis in children with sickle cell disease in Brent. BMJ. 1991;302(6783): 989-990.
7. 1-drenoceptor subtypes in human corpus cavernosum. J Urol. 1998;160:597-600.
8. Davila HH, Parker J, Webster JC, Lockhart JL, Carrion RE. Subarachnoid hemorrhage as a complication of phenyl ephrine injection for the treatment of ischemic priapism in a sickle cell disease patient. J Sex Med. 2008;5(4):1025-1028.
9. Levine LA, Guss SP. Gonadotrophin-releasing hormone analogues in the treatment of sickle cell anemia associated priapism. J Urol. 1993;150(2 Pt 1):475-477.
10. Lowe FC, Jarow JP. Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology. 1993;42(1):51-53; discussion 53-54.
11. Mantadakis E, Ewalt DH, Cavender JD, Rogers ZR, Buchanan GR. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood. 2000;95(1):78-82.
12. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A, Sharlip ID; Members of the Erectile Dysfunction Guideline Update Panel. American Urological Association guideline on the management of priapism. J Urol. 2003;170(4 Pt 1): 1318-1324.
13. Okpala I, Westerdale N, Jegede T, Cheung B. Etilefrine for the prevention of priapism in adult sickle cell disease. Br J Hematol. 2002;118(3):918-921.
14. Shamloul R, el Nashaar A. Idiopathic stuttering priapism treated successfully with low dose ethinyl estradiol: a single case report. J Sex Med. 2005;2(5):732-734.
15. Smith KH. Use of dicumarol in persistent priapism. J Urol. 2005; 64(2):400-402.
16. Strouse J, Lanzkron S, Beach MC, Haywood C, Park H, Witkop C, Wilson RF, Bass EB, Segal JB. Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics. 2008;122(6):1332-1342.
17. Teloken C, Ribeiro EP, Chammas M Jr, Teloken PE, Souto CA. Intracavernosal etilefrine self-injection therapy for recurrent priapism: one decade of follow-up. Urology. 2005;65(5):1002.
18. Thiel R, Kahn T, Vogeli TA. Idiopathic partial thrombosis of the corpus cavernosum. Urol Int. 1998;60(3):178-180.
19. Tripe JW. A case of continued priapism. Lancet. 1845;ii:8.
20. Virag R, Bachir D, Floresco J, Galacteros F, Dufour B. Ambulatory treatment and prevention of priapism using alpha-agonists. Apropos of 172 cases [in French]. Chirurgie. 1997;121(9-10): 648-652.
21. Yamashita N, Hisasue S, Kato R, Masumori N, Takahashi A, Itoh N, Tsukamoto T. Idiopathic stuttering priapism: recovery of Detumescence mechanism with temporal use of antiandrogen. Urology. 2004;63(6):1182-1184.